Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
FOEDAP TMS S.A. logo

EDAP TMS S.A. (FOCL)

NASDAQ Global Market · Currency in USD
$4.17 ▲ +0.02 (+0.48%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$4.15
Open
$4.48
Day's Range
$4.13 – $4.48
52 Week Range
$1.75 – $6.40
Volume
27,393
Avg. Volume
95,052
Market Cap
$156.30M
Beta (5Y Monthly)
-0.03
PE Ratio (TTM)
--
EPS (TTM)
-$1.04
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$9.67

Profile: EDAP TMS S.A.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
289
CEO
Ryan Rhodes

EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors.

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate -$0.24 · Revenue est. $11.39M
DateEst.Actual
Aug 13, 2026-$0.20-$0.39Miss
May 7, 2026-$0.20-$0.24Miss
Mar 25, 2026-$0.15-$0.25Miss
Nov 6, 2025-$0.25-$0.15Beat
Aug 28, 2025-$0.21-$0.18Beat
May 15, 2025-$0.16-$0.21Miss

Analyst view

Consensus price target
$9.67 ▲ +131.9%
Range $4.00 – $15.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on FOCL and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.